Evidence map›Paper›PMID 41009680›Full record

ArticleInternational journal of molecular sciences2025

Unveiling the Antibacterial Efficacy and Mechanistic Insights of MnO

Istikhori Fitriannisa, Hanny Tika Draviana, Cheng-Pei Hsieh, Muhammad Saukani, Kai-Yi Tzou, Tsung-Rong Kuo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Nanoengineered γ MnOLife (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Istikhori FitriannisaInternational PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City 23564, Taiwan.
Hanny Tika DravianaInternational PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City 23564, Taiwan.
Cheng-Pei HsiehSchool of Biomedical Engineering, Taipei Medical University, New Taipei City 23564, Taiwan.
Muhammad SaukaniDepartment of Mechanical Engineering, Faculty of Engineering, Universitas Islam Kalimantan MAB, Banjarmasin 70124, Kalimantan Selatan, Indonesia.ORCID 0000-0001-5901-5205
Kai-Yi TzouDepartment of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.ORCID 0000-0001-9153-307X
Tsung-Rong KuoInternational PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City 23564, Taiwan.ORCID 0000-0003-4937-951X

Funding

National Science and Technology Council of Taiwan NSTC 114-2113-M-038-001
6 · The paper itself

Abstract

Pathogenic bacterial infections pose serious health risks, underscoring the need for timely treatments. Manganese dioxide (MnO

Indexed as

Anti-Bacterial AgentsManganese CompoundsMetal NanoparticlesNanoparticlesOxidesEscherichia coliMicrobial Sensitivity TestsReactive Oxygen SpeciesStaphylococcus aureusAnti-Bacterial AgentsManganese Compoundsmanganese dioxideOxidesReactive Oxygen Speciesantibacterial mechanismMnO2 nanoparticlereactive oxygen speciesSEM analysis

Identifiers

PMID41009680
PMCPMC12470811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.